Annexin A2 (ANXA2) (NM_001002857) Human Recombinant Protein from OriGene Technologies

Product Details
ItemAnnexin A2 (ANXA2) (NM_001002857) Human Recombinant Protein
CompanyOriGene Technologies
PriceSupplier Page
Catalog NumberTP305081
Quantity20 µg
Molecule NameANXA2

Add to Compare List

See More Life Science Supplies

OriGene Technologies

9620 Medical Center Drive

# 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only)
Phone: 301-340-3188
Fax: 301-340-9254

Company Profile

Website: www.origene.com/

(1) A monoclonal antibody against annexin A2 targets stem and progenitor cell fractions in tumorsTranslational OncologyJanuary 1, 2022Rajkumar S. Kalra, Gaurav S. Soman, Pradeep B. Parab, Avinash M. Mali, Sagar S. Varankar, Rutika R. Naik, Swapnil C. Kamble, Jaspreet K. Dhanjal, Sharmila A. Bapateither mAb150 immunoprecipitated (i) A4 cell lysates or (ii) purified commercial AnxA2 protein (Origene TP305081) with mab150 and commercial Annexin A2 antibody (sc-28,385) (Figs.1A-ii-v). The target protein was localized

(2) Anxa2 attenuates osteoblast growth and is associated with hip BMD and osteoporotic fracture in Chinese elderlyPLOS ONEMarch 23, 2018Xu Zhou et al.complete medium before treatment. The recombinant protein of human Annexin A2 (Origene, Catalogue No.TP305081) was then added to the medium generating various concentrations (0, 25, 50, 100, 200ng/ml). The experiment

Be the First to Write a Review!

Annexin A2 (ANXA2) (NM_001002857) Human Recombinant Protein from OriGene Technologies

Description

Company Info

OriGene Technologies

Citations (2)

Be the First to Write a Review!